Literature DB >> 22723221

Assessing cell and organ senescence biomarkers.

Bruno Bernardes de Jesus1, Maria A Blasco.   

Abstract

A major goal in cancer and aging research is to discriminate the biochemical modifications that happen locally that could account for the healthiness or malignancy of tissues. Senescence is one general antiproliferative cellular process that acts as a strong barrier for cancer progression, playing a crucial role in aging. Here, we focus on the current methods to assess cellular senescence, discriminating the advantages and disadvantages of several senescence biomarkers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723221      PMCID: PMC4824275          DOI: 10.1161/CIRCRESAHA.111.247866

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  217 in total

Review 1.  Immortalisation and transformation revisited.

Authors:  Sarah Drayton; Gordon Peters
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

2.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

Review 3.  Linking functional decline of telomeres, mitochondria and stem cells during ageing.

Authors:  Ergün Sahin; Ronald A Depinho
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

4.  Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia.

Authors:  Lawrence S Honig; Nicole Schupf; Joseph H Lee; Ming X Tang; Richard Mayeux
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

5.  High-throughput telomere length quantification by FISH and its application to human population studies.

Authors:  Andrés Canela; Elsa Vera; Peter Klatt; María A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

6.  Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.

Authors:  E González-Suárez; E Samper; J M Flores; M A Blasco
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

8.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

9.  Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts.

Authors:  H Tahara; E Sato; A Noda; T Ide
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

10.  A p53-dependent response limits epidermal stem cell functionality and organismal size in mice with short telomeres.

Authors:  Ignacio Flores; Maria A Blasco
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more
  61 in total

Review 1.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.

Authors:  Luigi Ferrucci; Elisa Fabbri
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

Review 2.  Drugs that target aging: how do we discover them?

Authors:  A Myers; G J Lithgow
Journal:  Expert Opin Drug Discov       Date:  2019-04-11       Impact factor: 6.098

3.  Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice.

Authors:  Sangmi Ock; Wang Soo Lee; Jihyun Ahn; Hyun Min Kim; Hyun Kang; Ho-Shik Kim; Daewoong Jo; E Dale Abel; Tae Jin Lee; Jaetaek Kim
Journal:  Endocrinology       Date:  2015-10-15       Impact factor: 4.736

4.  Techniques to Induce and Quantify Cellular Senescence.

Authors:  Nicole Noren Hooten; Michele K Evans
Journal:  J Vis Exp       Date:  2017-05-01       Impact factor: 1.355

5.  Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.

Authors:  Caroline Theresa Seebauer; Stefan Brunner; Gabriel Glockzin; Pompiliu Piso; Petra Ruemmele; Hans-Juergen Schlitt; Edward Kenneth Geissler; Stefan Fichtner-Feigl; Rebecca Kesselring
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

6.  Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.

Authors:  Yujiro Kida; Joseph A Zullo; Michael S Goligorsky
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

7.  Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Authors:  Emilija Manojlovic-Gacic; Milica Skender-Gazibara; Vera Popovic; Ivan Soldatovic; Novica Boricic; Savo Raicevic; Sandra Pekic; Mirjana Doknic; Dragana Miljic; Irina Alafuzoff; Fredrik Pontén; Olivera Casar-Borota
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

Review 8.  Telomerase at the intersection of cancer and aging.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Trends Genet       Date:  2013-07-19       Impact factor: 11.639

9.  Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells.

Authors:  Polina Goichberg; Ramaswamy Kannappan; Maria Cimini; Yingnan Bai; Fumihiro Sanada; Andrea Sorrentino; Sergio Signore; Jan Kajstura; Marcello Rota; Piero Anversa; Annarosa Leri
Journal:  Circulation       Date:  2013-10-18       Impact factor: 29.690

Review 10.  Systemic DNA damage responses in aging and diseases.

Authors:  Flavia Ribezzo; Yosef Shiloh; Björn Schumacher
Journal:  Semin Cancer Biol       Date:  2016-01-07       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.